Trial · NCT05073679
Registered outcomes62
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
41 to 60 of 62
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | Measured at enrollment for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 1 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 2 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 3 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 4 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 5 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 6 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 7 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 8 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | week 9 for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Columbia Suicide Severity Rating Scale (CSSRS) | 6 months after enrollment for patients age 17 or older | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores range from 1 (low risk) to 3 (high risk). |
| Other | Ask Suicide Screening Questions (ASQ) | Measured at enrollment for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 1 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 2 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 3 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 4 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 5 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 6 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 7 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
| Other | Ask Suicide Screening Questions (ASQ) | week 8 for patients age 16 or younger | Evidence-based metric evaluating for presence of suicidal ideation and severity. Scores include 1 (negative screen), 2 (non-acute positive screen), and 3 (acute positive screen). Higher scores represent higher suicidal ideation and higher risk of suicide. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05073679/registered?page=3